Надання медичної допомоги хворим на хронічну хворобу нирок V стадії




старонка12/12
Дата канвертавання24.04.2016
Памер1.76 Mb.
1   ...   4   5   6   7   8   9   10   11   12
Eur. J. Clin. Nutr. – 1996. – Vol. 50. – P. 295–301.

  • A Guide to the MalnutritionUniversal Screening Tool (MUST) for Adults / V. Todorovic, [et al.] // Brit. Ass. ParentEnteral. Nutr. (BAPEN), 2003.

  • Interdialytic weight gain and nutritional parameters in chronic hemodialysis patients / R. A. Sherman, R. P. Cody, M. E. Rogers, J. C. Solanchick // Am. J. Kidney Dis. – 1995. – Vol. 25. – P. 579–583.

  • Testa A. Clinical determinants of interdialytic weight gain / A. Testa, A. Plou // J. Ren. Nutr.2001. – Vol. 11. – P. 155–160.

  • Caloric rather than protein deficiency predominates in stable chronic haemodialysis patients / V. Lorenzo, de BE, M. Rufino [et al.] // Nephrol. Dial. Transplant. – 1995. – Vol. 10. – P. 1885–1889.

  • Subjective global assessment ofnutrition in dialysis patients / G. Enia, C. Sicuso, G. Alati, C. Zoccali // Nephrol. Dial. Transplant. – 1993. – Vol. 8. – P. 1094–1098.

  • Improvement innutritional parameters after initiationof chronic hemodialysis / L. B. Pupim, P. Kent, K. Caglar [et al.] // Am J Kidney Dis – 2002. – Vol. 40. – P. 143–151.

  • Changes in body fat mass in male hemodialysis patients: a comparisonbetween diabetics and nondiabetics / S. Okuno, E. Ishimura, M. Kim [et al.] // Am J Kidney Dis – 2001. – Vol. 38. – P. 208–211.

  • Dialysi Outcomes and Practice Patterns Study (DOPPS) DataonMedicationin Hemodialysis Patients / V. E. Andreucci, R. B. Fissell, J. L. Bragg-Gresham [et al.] // Am J Kidney Dis – 2004. – Vol. 44, Suppl 2. – P. 61–67.

  • International variations in vitamin prescriptionand associationwith mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) / R. B. Fissell, J. L. Bragg-Gresham, B. W. Gillespie [et al.] // Am J Kidney Dis – 2004. – Vol. 44. – P. 293–299.

  • Chazot C., Kopple J. D. Vitamin metabolism and requirements in renal disease and renal failure.InNutritional Management of Renal Disease, Kopple J. D., Massry S. G., Eds, 2nd edn, Lipincott Williams and Wilkins, Philadelphia, USA: 2004;315–356

  • Water soluble vitamins in chronic hemodialysis patients and needs for supplementation / E. Descombes, A. B. Hanck, G. Fellay // Kidney Int. – 1993. – Vol. 43. – P. 1319–1328.

  • Wiggins K. L. Renal Care: Resources and practical applications. Renal Dietitians Dietetic Practice Group: Am Diet Ass. – 2003. – P. 51–52.

  • Plasma ascorbic acid in patients undergoing chronic haemodialysis / S. Wang, T. C. Eide, E. M. Sogn [et al.] // Eur J Clin Pharmacol – 1999. – Vol. 55. – P. 527–532.

  • Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial / V. Giancaspro, M. Nuziello, G. Pallotta [et al.] // J Nephrol – 2000. – Vol. 13. – P. 444–449.

  • Low dose intravenous ascorbic for erythropoietin hypo-responsive anaemia in diabetic haemodialysis patients with ironoverload / C. L. Lin, P. Y. Hsu, H. Y. Yang [et al.] // Ren Failure – 2003. – Vol. 25. – P. 443–453.

  • Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients / K. Keven, S. Kutley, G. Nergizoglu [et al.] // Am. J. Kidney Dis. – 2003. – Vol. 41. – P. 1233–1239.

  • A randomized double blind placebo controlled trial of supplementary vitamin E, C and their combinationfor treatment of haemodialysis cramps / P. Khajehdehi, M. Mojerlou, S. Behzadi [et al.] // Nephrol Dial Transplant – 2001. – Vol. 16. – P. 1448–1451.

  • Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients / R. Deicher, F. Ziai, C. Bieglmayer [et al.] // J Am Soc Nephrol – 2005. Vol. 16. – P. 1811–1818.

  • Impact of high-flux/high-efficiency dialysisonfolate and homocysteine metabolism / C. Lasseur, F. Parrot, Y. Delmas [et al.] // J Nephrol – 2001. – Vol. 14. – P. 32–35.

  • Rostand S. G. Vitamin B12 levels and nerve conduction velocities in patients undergoing maintenance hemodialysis / S. G. Rostand // Am. J Clin Nutr. – 1976. – Vol. 29. – P. 691–697.

  • Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease / L. N. Kaplan, O. A. Mamer, L. J. Hoffer // Clin Invest Med – 2001. – Vol. 24. – P. 5–11.

  • B12 in maintenance hemodialysis patients receiving massive supplementationof vitamin B12 / G. Mangiarotti, C. Canavese, M. Salomone [et al.] // Int J Artif Organs. – 1986. – Vol. 9. – P. 417–420.

  • Nicotinamide suppresses hyperphosphatemia in hemodialysis patients / Y. Takahashi, A. Tanaka, T. Nakamura [et al.] // Kidney Int. – 2004. – Vol. 65. – P. 1099–1104.

  • Rottembourg J. B. Thrombocytopenia induced by nicotinamide in hemodialysis patients / J. B. Rottembourg, V. Launay-Vacher, J. Massard // Kidney Int – 2005. – Vol. 68. – P. 2911–2912.

  • Diabetes Multicenter Research Group. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial / S. M. Grundy, G. L. Vega, M. E. McGovern [et al.] // Arch Intern Med – 2002. – Vol. 162. – P. 1568–1576.

  • Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project) / P. L. Canner, C. D. Furberg, M. L.Terrin, M. E. McGovern // Am J Cardiol – 2005. – Vol. 95. – P. 254–257.

  • K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease // Am J Kidney Dis – 2003. – Vol. 42, Supp. 3. – P 1–201.

  • Malnutrition in long-term haemodialysis survivors / C. Chazot, G. Laurent, B. Charra [et al.] // Nephrol Dial Transplant – 2001. – Vol. 16. – P. 61–69.

  • Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomised placebo-controlled trials / M. Boaz, S. Smetena, T. Weinstein [et al.] // Lancet – 2000. – Vol. 356. – P. 1213–1218.

  • Bone health of adult hemodialysis patients is related to vitamin K status / M. Kohlmeier, J. Saupe, M. J. Shearer [et al.] // Kidney Int. – 1997. – Vol. 51. – P. 1218–1221.

  • Dietary references intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids / P. Trumbo, S. Schlicker, A. A. Yates [et al.] // J Am Diet Assoc – 2002. – Vol. 102. – P. 1621–1630.

  • Locatelli F. European Best Practice Guidelines Working Group. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure / F. Locatelli, P. Aljama, P. Barany // Nephrol Dial Transplant – 2004. – Vol. 19, Suppl. 2. – P. 1–47.

  • The effect of diet educationonthe laboratory values and knowledge of hemodialysis patients with hyperphosphatemia / J. C. Ford, J. F. Pope, A. E. Hunt, B. Gerald // J Renal Nutr -2004. – Vol. 14. – P.36–44.

  • Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients / R. Galland, J. Traeger, W. Arkouche [et al.] // Kidney Int – 2001. – Vol. 60. – P. 1555–1560.

  • Dietary salt restriction and reductionof dialysate sodium to control hypertension in maintenance haemodialysis patients / S. Krautzig, U. Janssen, K. M. Koch [et al.] // Nephrol Dial Transplant – 1998. – Vol. 13. – P. 552–553.

  • Beto J. A. Medicalnutritiontherapy in chronic kidney failure: integrating clinical practiceguidelines / J. A. Beto, V. K. Bansal // J Am Diet Assoc – 2004. – Vol. 104. – P. 404–409.

  • Thomas B.Manual of Dietetic Practice // Brit Diet Ass, 3rd edn, London, 2001 – P. 182–183.

  • Dietary Reference Values for Food Energy and Nutrients for the UnitedKingdom.Department of Health ReportonHealth and Social Subjects, 1991 – Vol. 41. – P. 1–210.

  • Zinc supplementationat conventional doses does not improve the disturbance of taste perceptionin HD patients / A. Matson, M. Wright, A. Oliver [et al.] // J Renal Nutr – 2003. – Vol. 13. – P. 224–228.

  • Trace elements and vitamins in maintenance dialysis patients / K. Kalantar-Zadeh, J. D. Kopple // Adv Renal Repl Therapy – 2003. – Vol. 10. – P. 170–182.

  • Effects of zinc supplementationon zinc status and immunity in haemodialysis patients / P. M. Kouw, C. H. Jonings, de Vries [et al.] // J Trace Elem Electrolyte Health Disease – 1991. – Vol. 5. – P. 115–119.

  • Effects of zinc supplementation onthe immune system andonantibody response to multivalent influenza vaccine in hemodialysis patients / S. Turk, S. Bozfakioglu, S. T. Ecder [et al.] // Int J Artif Organs – 1998. – Vol. 21. – P. 274–278.

  • The effects of zinc supplementation on serum zinc concentration and protein catabolic rate in HD patients / N. A. Jern, A. D. VanBeber, M. A. Gorman [et al.] // J Renal Nutr – 2000. – Vol. 10, 148–153.

  • The effects of zinc supplementation on serum zinc and cholesterol concentrations in HD patients / C. A. Chevalier, G. L. Liepa, M. D. Murphy [et al.] // J Renal Nutr – 2002. – Vol. 12: 183–189.

  • Thyroid function and plasma selenium in chronic uremic patientsonhemodialysis treatment / G. Napolitano, Bonomini, G. Bomba [et al.] // Biol Trace Element Research – 1996. – Vol. 55. – P. 221–230.

  • Effects of selenium supplementation on immune parameters in chronic uraemic patients onhaemodialysis / M. Bonomini, S. Forster, F. De Risio [et al.] // Nephrol. Dial. Transplant. – 1995. – Vol. 10. – P. 1654–1661

  • Reversal of selenium and zinc deficiencies in chronic hemodialysis patients by intravenous sodium selenite and zinc gluconate supplementation. Time-course of glutathione peroxidase repletionand lipid peroxidationdecrease / Richard MJ, Ducros V, Foret M et al. // Biol Trace Elem Res – 1993. – Vol. 39. – P. 149–159.

  • Lowrie E. G. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities / Lowrie EG, Lew NL. // Am J Kidney Dis – 1990. – Vol. 15. – P. 458–482.

  • Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS) / J. Bommer, F Locatelli, S Satayathum [et al.] // Am J Kidney Dis – 2004. – Vol. 44. – P. 661–671.

  • High bicarbonate dialysate in haemodialysis patients: effects on acidosis and nutritional status / A. J. Williams, I. D. Dittmer, A. McArley, J. Clarke // Nepholr Dial Transplant - 1997. – Vol. 12, P. 2633–2637.

  • Correctionof metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study / E. Movilli, R. Zani, O. Carli [et al.] // Nephrol. Dial. Transplant. – 1998. – Vol. 13. – P. 1719–1722.

  • Effect of the correctionof metabolic acidosis on nutritional status in elderly patients with chronic renal failure / C. Verove, N. Maisonneuve, A. A. El [et al] // J. Renal. Nutr. – 2002. – Vol. 12. – P. 224–228.

  • Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients / E. Movilli, N. Bossini, B. F. Viola [et al.] // Nephrol. Dial. Transplant. – 1998. – Vol. 13. – P. 674–678.

  • Blair D. Nutritional effects of delivered bicarbonate dose in maintenance hemodialysis patients / D. Blair, C. Bigelow, S. J.Sweet // J. Renal. Nutr. – 2003. – Vol. 13. – P. 205–211.


  • 1   ...   4   5   6   7   8   9   10   11   12


    База данных защищена авторским правом ©shkola.of.by 2016
    звярнуцца да адміністрацыі

        Галоўная старонка